Beta
Back to CVS.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
eps-chart

CVS EPS

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for CVS's EPS in Q4'25 stands at 2.33 USD, marking a significant recovery from the sharp decline in the prior quarter and representing the highest value in the observed period from Q1'23 to Q4'25. Over the 12-quarter timeframe, CVS's EPS exhibited high volatility with an overall fluctuating trend, starting at 1.66 USD in Q1'23 and peaking at 2.33 USD in Q4'25, but featuring notable declines such as a drop to 0.07 USD in Q3'24 and a plunge to -3.13 USD in Q3'25 amid operational challenges. Year-over-year EPS growth was predominantly negative, with severe contractions like -96% in Q3'24 and an extreme -4,571% in Q3'25, though sporadic rebounds occurred, including +168% in Q3'23 and +78% in Q4'25, underscoring inconsistent profitability driven by sector-specific pressures in healthcare retail.